🔎 Trials Near Me

Dachaigh › Aillse Prostata › Oregon

Sgrùdaidhean clionaigeach Aillse Prostata ann an Oregon

Tha 38 sgrùdaidhean airson Aillse Prostata a’ lorg phàirtichean aig làraichean ann an Oregon.

Bailtean ann an Oregon

Teacsa sgrùdaidh oifigeil (Beurla)

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

  • VA Portland Health Care System, Portland, OR, Portland
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 5 Dàmh 2026 · NCT05593497

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Oregon Health & Science University (OHSU), Portland
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 2 Dàmh 2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Oregon Health and Science University, Portland
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06632977

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Saint Alphonsus Cancer Care Center-Baker City, Baker City
  • Saint Charles Health System, Bend
  • Clackamas Radiation Oncology Center, Clackamas
  • agus 7 a bharrachd
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Saint Alphonsus Cancer Care Center-Ontario, Ontario
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT03866382

Precision-Based Genomics in Prostate Cancer

  • Oregon Health Sciences University, Portland
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Fir · Air ùrachadh 28 Sult 2026 · NCT04706663

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • Oregon Health And Science University, Portland
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 28 Sult 2026 · NCT06095089

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

  • Providence Portland Medical Center, Portland
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 24 Sult 2026 · NCT07543055

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • Oregon Oncology Specialists, Salem
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 22 Sult 2026 · NCT07213674

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Springfield
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 18 Sult 2026 · NCT06952803

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • VA Portland Health Care System, Portland, OR, Portland
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Sult 2026 · NCT04038502

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • VA Portland Health Care System, Portland, OR, Portland
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Sult 2026 · NCT05011383

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • VA Portland Health Care System ( Site 0038), Portland
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Sult 2026 · NCT06925737

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Oregon Urology, Springfield
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 11 Sult 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Saint Charles Health System, Bend
  • Clackamas Radiation Oncology Center, Clackamas
  • Providence Portland Medical Center, Portland
  • agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 10 Sult 2026 · NCT05946213

MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

  • Oregon Health & Science University, Portland
A’ fastadh
Aoisean 18 agus nas sine · Fir · Air ùrachadh 1 Sult 2026 · NCT05710380

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

  • Oregon Health & Science University, Portland
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 31 Lùna 2026 · NCT05726292

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

  • Research Site, Portland
A’ fastadhÌre 1/2
Aoisean 18 gu 99 · Fir · Air ùrachadh 27 Lùna 2026 · NCT07590934

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Portland
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 26 Lùna 2026 · NCT07611110

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Saint Charles Health System, Bend
  • Clackamas Radiation Oncology Center, Clackamas
  • Bay Area Hospital, Coos Bay
  • agus 5 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 19 Lùna 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Oregon Health and Science University, Portland
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT05919264

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Saint Charles Health System, Bend
  • Clackamas Radiation Oncology Center, Clackamas
  • Bay Area Hospital, Coos Bay
  • agus 8 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 14 Iuch 2026 · NCT06592924

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

  • Oregon Health & Science University, Portland
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 25 Ògmh 2026 · NCT06457919

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

  • VA Portland Health Care System, Portland
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 15 Ògmh 2026 · NCT05422911

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  • Oregon Health & Science University Hospital, Portland
A’ fastadhSgrùdadh amharc
Aoisean 21 agus nas sine · Fir · Air ùrachadh 22 Cèit 2026 · NCT03151629

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

  • OHSU Knight Cancer Institute, Portland
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 agus nas sine · Fir · Air ùrachadh 15 Cèit 2026 · NCT04472338

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

  • Research Site, Portland
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 12 Cèit 2026 · NCT06879041

Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE

  • OHSU Knight Cancer Institute, Portland
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Cèit 2026 · NCT06011499

GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer

  • OHSU Knight Cancer Institute, Portland
A’ fastadh
Aoisean 65 agus nas sine · Fir · Air ùrachadh 6 Cèit 2026 · NCT07504835

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  • Saint Alphonsus Medical Center-Baker City, Baker City
  • Saint Charles Health System, Bend
  • Clackamas Radiation Oncology Center, Clackamas
  • agus 9 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 29 Faoi 2026 · NCT05806515

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

  • Saint Alphonsus Cancer Care Center-Baker City, Baker City
  • Saint Alphonsus Cancer Care Center-Ontario, Ontario
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 22 Faoi 2026 · NCT06470243

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Oregon Health Sciences University, Portland
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Portland
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

EMBRACE: Exercising Together

  • OHSU Knight Cancer Institute, Portland
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Cèit 2025 · NCT06049355

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

  • VA Portland Healthcare System, Portland
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 20 Gibl 2022 · NCT03753243

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.